MEDICINOVA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $7.92K, a 97.97% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $249.61K, a 32.74% increase year-over-year.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $389.74K, a 11.07% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $212.18K.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $7.92K, a 99.11% decline from fiscal 2021.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $890.24K, a 1.74% decline from fiscal 2020.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $905.97K, a 78.00% decline from fiscal 2019.
- MEDICINOVA, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $4.12M, a 911.48% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $7.92K 10-K · filed 2024-02-15 | |
| 2022-06-30 | $7.92K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $890.24K 10-K/A · filed 2023-03-28 | |
| 2021-09-30 | $249.61K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $389.74K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $212.18K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $905.97K 10-K · filed 2022-02-16 | |
| 2020-09-30 | $188.05K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $438.26K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $4.12M 10-K · filed 2021-02-19 | |
| 2019-06-30 | $180.37K 10-Q · filed 2020-10-26 | $4.10M derived: sum of 4 quarters · filed 2020-10-26 |
| 2019-03-31 | $3.92M 10-Q · filed 2020-10-26 | $3.92M derived: sum of 4 quarters · filed 2020-10-26 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $407.20K 10-K · filed 2020-02-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | |
| 2018-03-31 | $407.20K 10-Q · filed 2019-10-24 | |
| 2017-12-31 | $426.01K 10-K · filed 2019-02-13 | |
| 2016-12-31 | $829.53K 10-K · filed 2019-02-13 | |
| 2014-12-31 | $51.35K 10-K · filed 2017-02-14 | |
| 2013-12-31 | $193.95K 10-K · filed 2015-03-12 | |
| 2012-12-31 | -$270.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $137.73K 10-K · filed 2014-03-27 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $138.00K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $263.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $76.26K 10-K · filed 2013-03-28 |
| 2011-09-30 | $2.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $66.00K 10-Q · filed 2012-08-09 | |
| 2010-12-31 | $166.60K 10-K · filed 2013-03-28 | |
| 2009-12-31 | $406.36K 10-K · filed 2013-03-28 | |
| 2006-12-31 | $14.00K 10-K · filed 2013-03-28 | |
| 2005-12-31 | $5.56M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |